Alpine Woods Capital Investors’s GSK GSK Stock Holding History

Alpine Woods Capital Investors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-8,440	Closed	-$403K	–	272
2018 Q4	$403K	Hold	8,440	–	–	0.1%	189
2018 Q3	$424K	Buy	+8,440	New	+$429K	0.09%	169
2015 Q3	–	Sell	-8,000	Closed	-$417K	–	483
2015 Q2	$417K	Hold	8,000	–	–	0.02%	337
2015 Q1	$462K	Hold	8,000	–	–	0.02%	334
2014 Q4	$427K	Buy	+8,000	New	+$448K	0.02%	337

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Alpine Woods Capital Investors's GSK Position: Q1 2019 in Review

Alpine Woods Capital Investors sold out of GSK (GSK) in Q1 2019, closing a stake of 8,440 shares — an estimated $403K sold.

Alpine Woods Capital Investors first reported a position in GSK in Q4 2014 and held it in 5 quarters. The position peaked at $462K in Q1 2015. 848 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

Alpine Woods Capital Investors reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
Alpine Woods Capital Investors sold 8,440 GSK shares in Q1 2019, an estimated $403K.
Alpine Woods Capital Investors first reported a position in GSK in Q4 2014 and held it in 5 quarters.
Alpine Woods Capital Investors's GSK position peaked at $462K in Q1 2015.
848 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Alpine Woods Capital Investors's 13F filing for Q1 2019, filed 6 May 2019.